Background-Angiotensin (Ang) II-induced target-organ damage involves innate and acquired immunity. Mice deficient for the helix-loop-helix transcription factor inhibitor of differentiation (Id2 Ϫ/Ϫ ) lack Langerhans and splenic CD8aϩ dendritic cells, have reduced natural killer cells, and have altered CD8 T-cell memory. We tested the hypothesis that an alteration in the number and quality of circulating blood cells caused by Id2 deletion would ameliorate Ang II-induced target-organ damage. Methods and Results-We used gene-deleted and transgenic mice. We conducted kidney and bone marrow transplants. In contrast to Ang II-infused Id2 ϩ/Ϫ , Id2 Ϫ/Ϫ mice infused with Ang II remained normotensive and failed to develop albuminuria or renal damage. Bone marrow transplant of Id2 ϩ/Ϫ bone marrow to Id2 Ϫ/Ϫ mice did not restore the blunted blood pressure response to Ang II. Transplantation of Id2 Ϫ/Ϫ kidneys to Id2 ϩ/Ϫ mice also could not prevent Ang II-induced hypertension and renal damage. We verified the Ang II resistance in Id2 Ϫ/Ϫ mice in a model of local tissue Ang II production by crossing hypertensive mice transgenic for rat angiotensinogen with Id2 Ϫ/Ϫ or Id2 ϩ/Ϫ mice. Angiotensinogen-transgenic Id2 ϩ/Ϫ mice developed hypertension, albuminuria, and renal injury, whereas angiotensinogen-transgenic Id2 Ϫ/Ϫ mice did not. We also found that vascular smooth muscle cells from Id2 Ϫ/Ϫ mice showed an antisenescence phenotype.
(Id2 Ϫ/Ϫ ) mice show structural and functional conduction system abnormalities, including left bundle-branch block. 11 
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Changes in vascular smooth muscle cell (VSMC) differentiation play a key role in vascular diseases, yet the mechanisms that control VSMC differentiation are largely undefined. A potential role for Id2 in the control of VSMC differentiation and phenotypic modulation has been suggested. Both enhanced VSMC growth and inhibition of VSMC differentiation marker genes have been observed in response to Id2 overexpression. 12, 13 Id2 Ϫ/Ϫ mice lack Langerhans and splenic CD8aϩ dendritic cells, have reduced natural killer cells, and have altered CD8 T-cell memory. 14 -17 We used Id2 Ϫ/Ϫ mice to analyze whether or not alterations in circulating blood cells and function would ameliorate Ang II-induced target-organ damage.
Methods

Experimental Animals
Id2 mutants (Id2 Ϫ/Ϫ ) and Id2 ϩ/Ϫ controls were backcrossed more than 7 generations on an NMRI (Naval Medical Research Institute) background. Mice were generated as described previously 17 and were bred and maintained in the animal facility of the Max Delbrück Center. We followed the American Physiological Society guidelines for animal care, and the Animal Use Committee of Berlin approved the studies.
In protocol I, male age-matched Id2 Ϫ/Ϫ and Id2 ϩ/Ϫ controls were continuously infused with Ang II (1.44 mg · kg Ϫ1 · d Ϫ1 SC by minipump infusion for 2 weeks; nϭ8 and 12, respectively). To dissect the role of circulating from tissue Id2, we performed protocol II. After lethal irradiation, bone marrow from Id2 ϩ/Ϫ mice was transplanted to Id2 ϩ/Ϫ controls (nϭ11) or Id2 Ϫ/Ϫ mice (nϭ7), or bone marrow from Id2 Ϫ/Ϫ mice was transplanted to Id2 ϩ/Ϫ controls (nϭ12). In protocol III, we transplanted Id2 Ϫ/Ϫ kidneys to Id2 ϩ/Ϫ mice (nϭ5) as described in detail elsewhere. 18 Mice in protocols II and III were infused with Ang II as described in protocol I. In protocol IV, we crossed WTϫId2 Ϫ/Ϫ mice with rat angiotensinogen (Aogen)-transgenic (TGM) Id2 ϩ/Ϫ mice to investigate the role of tissue Ang II in this model (nϭ30 for TGMϫId2 ϩ/Ϫ and nϭ17 for TGMϫId2 Ϫ/Ϫ ). Mice transgenic for rat Aogen have been described elsewhere. 19 Nontransgenic age-matched WTϫId2 ϩ/Ϫ (nϭ30) and WTϫId2 Ϫ/Ϫ (nϭ15) mice were used as controls. During our initial analysis, we compared Aogen-transgenic Id2 ϩ/ϩ with Aogentransgenic Id2 ϩ/Ϫ mice to evaluate the impact of Id2 heterozygosity on target-organ damage. We found no difference with regard to mean arterial pressure (MAP), cardiac hypertrophy, albuminuria, and renal fibrosis between the groups (Data Supplement, Figure I ). Therefore, we continued our further analysis with Id2 ϩ/Ϫ mice as controls.
MAP was measured by radiotelemetry via an intracarotid catheter. 20 Baseline MAP was averaged over a 3-day period 10 days after implantation of the telemetry transmitter. In protocols I, II, and III, MAP was averaged from day 8 to day 10 after Ang II infusion (nϭ5 per group). Urine samples were collected during a 24-hour period 2 days before and 11 days after Ang II infusion. We measured urinary albumin by ELISA (CellTrend, Luckenwalde, Germany). Animals were euthanized at week 13 for protocols I and IV and at week 17 for protocols II and III, respectively.
Immunohistochemistry, Histology, Cell Culture, and Reverse-Transcription Polymerase Chain Reaction
Immunohistochemistry and histology were performed as described previously. 7, 8 Details about the procedure, including the quantification of infiltrated cells, are given in the Data Supplement. Aortic VSMCs were isolated from Id2 ϩ/Ϫ , Id2 Ϫ/Ϫ , and AT1 A Ϫ/Ϫ mice as described previously, 21 and passages 5 to 9 were used for the experiments. For details about the cellular senescence analyses and the TaqMan real-time polymerase chain reaction experiments, please refer to the Data Supplement.
Statistical Analysis
Data are presented as meanϮSEM. Statistically significant differences in mean values were tested by ANOVA, and when significance was indicated, the Scheffé post hoc test was used to discern differences between specific groups. In Figure 1A , the area under the curve was calculated for each individual experiment (nϭ5 for Id2 Ϫ/Ϫ versus nϭ6 for Id2 ϩ/Ϫ ). Thereafter, statistical differences were tested by ANOVA and post hoc Scheffé test. In addition, we also tested blood pressure differences by repeated-measures ANOVA followed by Scheffé test. In the renal transplant experiments in the present study, we used paired t test analysis to evaluate statistical differences for pre-and post-Ang II infusion. A value of PϽ0.05 was considered statistically significant. The data were analyzed with Statview statistical software.
The authors had full access to the data and take full responsibility for its integrity. All authors have read and agree to the manuscript as written.
Results
Id2 ؊/؊ Mice Are Resistant to Ang II-Induced Hypertension
To investigate the effect of Id2 on the development of hypertension and target-organ damage, we infused Ang II in Id2 ϩ/Ϫ and Id2 Ϫ/Ϫ mice. During the first day of Ang II infusion, both groups showed a transient increase in MAP that might have been due to postoperative stress and/or Ang II ( Figure 1A ). Thereafter, blood pressure in Id2 Ϫ/Ϫ mice returned to normal and remained normal until the end of Ang II infusion. In contrast, Ang II induced significant hypertension in Id2 ϩ/Ϫ mice, which persisted during the entire protocol ( Figure 1A ). The areas under the blood pressure curves, which indicate the pressure load over the entire experiment, were significantly different between the 2 groups. Furthermore, we found that from day 2 after Ang II infusion, blood pressure in Id2 ϩ/Ϫ mice was significantly increased at each time point compared with Id2 Ϫ/Ϫ mice. After Ang II treatment, albuminuria was significantly higher in Id2 ϩ/Ϫ mice than in Id2 Ϫ/Ϫ mice (240Ϯ37 versus 33Ϯ9 g/d, respectively, PϽ0.05; Figure 1B ). Masson trichrome stains of kidney Id2 Ϫ/Ϫ mice were not able to maintain high MAP over the infusion period. B, Ang II-infused Id2 ϩ/Ϫ mice showed significantly increased 24-hour albuminuria compared with Id2 Ϫ/Ϫ mice. C, Kidney damage after Ang II infusion. Masson trichrome stain shows that Id2 ϩ/Ϫ mice developed media hypertrophy, extracellular matrix depositions, and tubular changes, whereas no histopathological changes were observed in Id2 Ϫ/Ϫ mice. D, AT1 receptor immunoreactivity in renal vessels was higher in Id2 ϩ/Ϫ than in Id2 Ϫ/Ϫ mice. E, AT1 A receptor mRNA expression was higher in Id2 ϩ/Ϫ than in Id2 Ϫ/Ϫ VSMCs. Nevertheless, Id2 Ϫ/Ϫ VSMCs showed abundant expression compared with AT1 A Ϫ/Ϫ receptor VSMCs. F, AT1 B receptor mRNA expression was higher in Id2 Ϫ/Ϫ than in Id2 ϩ/Ϫ VSMCs, whereas AT1 A Ϫ/Ϫ receptor VSMCs had little expression. G, Dose-dependent blood pressure increase with intravenous bolus injections of phenylephrine (PE) and Ang II in Id2 ϩ/Ϫ and Id2 Ϫ/Ϫ mice. Results are meanϮSEM. *PϽ0.05 vs Id2 ϩ/Ϫ mice. sections showed increased vascular and tubular damage and greater matrix production in Ang II-treated Id2 ϩ/Ϫ mice than in Id2 Ϫ/Ϫ mice ( Figure 1C ). Ang II-treated Id2 Ϫ/Ϫ mice showed normal histology without perivascular matrix formation.
We next investigated whether altered renal gene expression of renin-angiotensin system components was responsible for the effect on blood pressure and renal damage in Id2 Ϫ/Ϫ mice. Total renal AT1 A and AT1 B receptor, AT2 receptor, AT1 receptor-associated protein (ATRAP), and ACE-2 mRNA expression was not altered either by Id2 deficiency or by Ang II infusion (Data Supplement Figure II) . Interestingly, AT1 A immunoreactivity from renal Id2 ϩ/Ϫ vessels was significantly higher than from Id2 Ϫ/Ϫ vessels ( Figure 1D ). AT1 A but not AT1 B mRNA was decreased in primary VSMCs from Id2 Ϫ/Ϫ compared with Id2 ϩ/Ϫ ( Figure 1E and 1F). To better understand the qualitative change, we compared AT1 receptor expression with VSMCs isolated from AT1 A receptor genedeleted mice. AT1 A and AT1 B receptor expression was much higher in Id2 Ϫ/Ϫ VSMCs than in AT1 A receptor-deficient VSMCs ( Figure 1E and 1F).
We next determined whether vessels from Id2 Ϫ/Ϫ mice had a major defect in vascular contraction. Acute intravenous bolus injections of either phenylephrine or Ang II increased blood pressure to the same magnitude in both Id2 genotypes ( Figure 1G ). Furthermore, the lower AT1 A receptor expression in renal vessels had no effect on the Ang II pressure response in acute experiments ( Figure 1G ). In addition, chronic administration of the nitric oxide synthase inhibitor N G -nitro-L-arginine methyl ester (L-NAME) increased MAP in Id2 ϩ/Ϫ mice (from 115Ϯ1 to 120Ϯ0.4 mm Hg after L-NAME) and Id2 Ϫ/Ϫ mice (from 105Ϯ3 to 121Ϯ8 mm Hg after L-NAME). These data indicate that Id2 Ϫ/Ϫ mice are able to respond to vasoactive stimuli.
Tissue-Specific Expression of Id2 and Blood Pressure Regulation
To dissect the role of Id2 in immune cells compared with other cell types in the development of hypertension, we performed bone marrow transfer after lethal irradiation (Figure 2A) . After full engraftment, all 3 groups were normotensive ( Figure 2B ). Infusion of Ang II for 2 weeks in Id2 ϩ/Ϫ mice with bone marrow from Id2 ϩ/Ϫ or Id2 Ϫ/Ϫ mice resulted in a significantly increased MAP (146Ϯ5 and 146Ϯ7 mm Hg, respectively, PϽ0.05; Figure 2B ). In contrast, Ang IIinduced hypertension in Id2 Ϫ/Ϫ mice with bone marrow from Id2 ϩ/Ϫ mice was not sustained ( Figure 2B ). Furthermore, both hypertensive groups developed albuminuria (267Ϯ53 and 210Ϯ70 g/d; Figure 2C ) and histological alterations ( Figure  2D ), whereas Id2 Ϫ/Ϫ mice with normal circulating blood cells were protected against albuminuria (26Ϯ6 g/d, PϽ0.05) and did not develop renal pathology. The data indicate that Id2 in tissues, rather than the alterations in immune cells, is responsible for the reduced hypertensive response and tissue damage in Id2 Ϫ/Ϫ mice.
To test the hypothesis that Id2 deficiency in the kidney plays a major role in the regulation of blood pressure, we performed kidney transplant experiments ( Figure 2E ). Uninephrectomized Id2 ϩ/Ϫ mice that received Id2 Ϫ/Ϫ kidneys were normotensive (114Ϯ3 mm Hg). After Ang II infusion, MAP increased 51 mm Hg to 165Ϯ10 mm Hg (PϽ0.01 versus baseline; Figure 2F ). Ang II infusion in uninephrectomized Id2 ϩ/Ϫ mice with Id2 Ϫ/Ϫ kidneys resulted in a 60-fold increase in albuminuria compared with baseline (PϽ0.05; Figure 2G ). Histology of the Ang II-infused transplanted Id2 Ϫ/Ϫ kidneys showed severe renal damage ( Figure 2H ). These results suggest that renal Id2 does not mediate hypertension and renal damage.
Effect of Local Ang II on Blood Pressure in Id2 Mutants
Local Ang II formation depends on local synthesis and could possibly give results different from long-term Ang II infusion. We therefore next validated our results using a transgenic mouse (TGM) overexpressing rat angiotensinogen. In this model, mouse renin cleaves rat angiotensinogen to generate Ang I and II, which leads to hypertension and target-organ damage. 20 To determine whether Id2 deficiency would lead to a similar phenotype in a model with endogenously elevated tissue Ang II, we mated TGMϫId2 ϩ/Ϫ mice with WTϫId2 Ϫ/Ϫ mice ( Figure 3A ). Here, we found that TGMϫId2 ϩ/Ϫ mice were hypertensive compared with TGMϫId2 Ϫ/Ϫ mice and the respective nontransgenic controls (141Ϯ3 versus 115Ϯ3 versus 107Ϯ2 and 107Ϯ2 mm Hg at week 12, respectively, PϽ0.05; Figure 3B ). Furthermore, TGMϫId2 ϩ/Ϫ mice developed significantly higher albuminuria (192Ϯ31 g/d at week 12; Figure 3C ). In contrast, albuminuria was normal in TGMϫId2 Ϫ/Ϫ mice and nontransgenic controls (26Ϯ4 versus 19Ϯ2 and 26Ϯ4 g/d at week 12, respectively; Figure 3C ). TGMϫId2 ϩ/Ϫ mice showed media hypertrophy, extracellular matrix deposition, and tubular damage, whereas TGMϫId2 Ϫ/Ϫ mice showed no obvious pathological changes ( Figure 3D ). Histology in nontransgenic control groups was normal. Consistent with these histological data, we found significantly increased levels of renal collagen IV (2.4Ϯ0.3 versus 0.4Ϯ0.3 versus 0.5Ϯ0.2 versus 0Ϯ0 arbitrary units [AU], PϽ0.05 TGMϫId2 ϩ/Ϫ versus other groups), fibronectin (2Ϯ0.3 versus 0.3Ϯ0.2 versus 0.5Ϯ0.3 versus 0Ϯ0 AU, PϽ0.05 TGMϫId2 ϩ/Ϫ versus other groups), and CD4 T-cell and macrophage infiltration in TGMϫId2 ϩ/Ϫ compared with TGMϫId2 Ϫ/Ϫ , WTϫId2 ϩ/Ϫ , and WTϫId2 Ϫ/Ϫ mice ( Figure 3E and 3F) . To exclude the possibility that Id2 deficiency influenced the expression of renin-angiotensin system components in TGM mice in the present study, we screened for rat angiotensinogen (TGMϫId2 ϩ/Ϫ 48Ϯ8 versus TGMϫId2 Ϫ/Ϫ 35Ϯ10 AU; PϭNS) and AT1 receptor expression (TGMϫId2 ϩ/Ϫ 7.6Ϯ1.6 versus TGMϫId2 Ϫ/Ϫ 8.5Ϯ1.2 AU; PϭNS) in the liver (TGMϫId2 ϩ/Ϫ 6.3Ϯ1.2 versus TGMϫId2 Ϫ/Ϫ 7.8Ϯ1.2 AU; PϭNS) and in the heart (TGMϫId2 ϩ/Ϫ 2.0Ϯ0.5 versus TGMϫId2 Ϫ/Ϫ 2.3Ϯ0.3 AU; PϭNS), as well as in the kidney.
Id2 Deficiency Shows Increased PPAR-␥ and Decreased PPAR-␣ Expression in VSMCs
We next wondered whether altered gene expression of Id2 Ϫ/Ϫ VSMC might be involved in our phenotype. Therefore, we isolated primary aortic VSMCs from Id2 ϩ/Ϫ and Id2 Ϫ/Ϫ mice, performed Affymetrix gene-array analysis, and identified genes from the peroxisome proliferator activator protein (PPAR) family. First, we confirmed the absence of Id2 mRNA in Id2 Ϫ/Ϫ VSMCs by TaqMan reverse transcription-polymerase chain reaction ( Figure 4A ). PPAR-␥ expression was 8-fold higher in Id2-deficent VSMCs than in Id2 ϩ/Ϫ VSMCs ( Figure 4B ). Conversely, we found that PPAR-␣ was downregulated, whereas PPAR-␤ was unchanged ( Figure 4B through 4D) . We also performed PPAR-␣ mRNA analyses in renal tissues (Data Supplement Figure II) . Surprisingly, we found that PPAR-␣ expression was equally highly expressed in all 4 groups in the present study, which could be related to the cell type heterogeneity in the kidney. Therefore, it might well be that other cell types besides VSMCs accounted for the total PPAR-␣ mRNA signal we detected. The total contribution of VSMCs to the overall renal content is likely to be relatively small.
Id2 Deficiency Protects VSMCs From Cellular Senescence
We also identified a cluster of genes involved in the regulation of cellular senescence, which we investigated in more detail. Cellular senescence can be defined as cell-cycle arrest that accompanies the exhaustion of replication potential. Senescent cells have a characteristic morphology. Furthermore, a low proliferation rate, marker expression of senescence-associated (SA)-␤-gal activity, and a typical pattern of cell-cycle regulators are also features of senescence. During the culturing process in higher passages (Ͼ6), Id2 ϩ/ϩ and Id2 ϩ/Ϫ VSMCs became enlarged in morphology, a characteristic of the senescence phenotype, whereas Id2 Ϫ/Ϫ VSMCs were smaller and flatter, with less cell-to-cell contact ( Figure 5A ). To ascertain whether Id2 is involved in senescence, we examined SA-␤-gal activity, a biomarker for cellular senescence. At pH 6, SA-␤-gal activity was increased in Id2 ϩ/Ϫ VSMCs compared with Id2 Ϫ/Ϫ VSMCs ( Figure 5B ). The progressive decrease in the proliferation potential followed by irreversible growth arrest is an important feature of senescence. We determined the level of bromodeoxyuridine incorporation after 24-hour starvation. Bromodeoxyuridine incorporation into the DNA of Id2 ϩ/Ϫ VSMCs was decreased compared with Id2 Ϫ/Ϫ VSMCs ( Figure 5C ). These results were confirmed by cell proliferation analysis ( Figure 5D ). To characterize the nature of cell-cycle arrest, we examined expression of cell-cycle regulatory proteins. We found that the presence of Id2 deficiency resulted in decreased mRNA expression of p16 INK4a , p21 Cip1 , collagen 1a1, and bone morphogenetic protein-4 ( Figure 5E ).
Discussion
The novel finding in the present study is that the helix-loophelix transcription factor Id2 plays a major role in the genesis of hypertension in response to Ang II. We showed in 2 Ang II-dependent models that Id2 Ϫ/Ϫ mice were resistant to hypertension and did not develop target-organ damage, even though their response to acute vasoconstrictors appeared to be preserved. Angiotensinogen-transgenic mice with additional Id2 deficiency and Id2 Ϫ/Ϫ mice infused with Ang II showed normal blood pressure and were protected from renal damage. In contrast, angiotensinogen-transgenic Id2 ϩ/Ϫ and Id2 ϩ/Ϫ mice infused with Ang II developed hypertension with elevated albuminuria, renal fibrosis, and inflammatory cell infiltration. Reconstitution of immune cells by bone marrow transplant did not restore the hypertension caused by Ang II in Id2 Ϫ/Ϫ mice, which indicates that Id2 in circulating blood cells, regardless of their Id2 expression, does not modulate blood pressure. Kidney transplant experiments demonstrated that extrarenal Id2 is most likely responsible for the lack of blood pressure sensitivity. Alternatively, the vessel wall could be a candidate tissue that might have been responsible for the insensitivity to Ang II-induced hypertension. Id2 deficiency resulted in an altered gene expression of PPAR-␣ and -␥ in primary VSMCs. Furthermore, the Id2 deficient-VSMCs showed an antisenescence phenotype.
Ang II plays a major role in the pathogenesis of cardiovascular disease. 3, 4, 22 Most of the actions of Ang II (for instance, regulation of blood pressure and water/salt balance) are mediated via the AT1 receptor. 4, 22 We first wondered whether the lack of Ang II sensitivity to maintain hypertension was solely affected by a simple downregulation of the AT1 receptor. This speculation seemed quite plausible because Aoki et al 23 reported that mice lacking Id2 developed hydronephrosis and had reduced AT1 receptor expression in the pelvis and ureter. These mice were bred on a mixed 129Sv background. In contrast, Id2 Ϫ/Ϫ mice in the present study, which were bred on a pure NMRI background, did not develop hydronephrosis and had unchanged AT1 A receptor mRNA expression in heart, liver, and total kidney. Therefore, genetic background might have been responsible for the development of hydronephrosis. When we performed a detailed analysis in the kidney and isolated VSMCs, we found the AT1 A receptor was significantly reduced in renal vessels and VSMCs. Nevertheless, AT1A receptor mRNA was abundantly expressed in Id2 Ϫ/Ϫ VSMCs compared with AT1 A Ϫ/Ϫ receptor VSMCs. In contrast, AT1 B receptor expression in the kidney and in VSMCs was not affected by Id2 deficiency. Apparently, the remaining vascular AT1 A and increased AT1 B receptor expression was sufficient for Ang II-induced vasoconstriction, because acute Ang II injections increased blood pressure to a similar extent in Id2-deficient and control mice. These results demonstrate that short-term Ang II-AT1 receptor signaling leads to vasoconstriction, whereas long-term blood pressure is impaired in Ang II-treated Id2 Ϫ/Ϫ mice.
A recent study by Crowley and colleagues 22 showed a very similar blood pressure profile as observed in the present study. They transplanted AT1 A Ϫ/Ϫ receptor kidneys into wildtype mice and observed a short transient rise in blood pressure after Ang II administration that could not be maintained over time. Increased natriuresis appeared to be the reason for the phenotype. 22 We performed kidney transplant to address the hypothesis that Id2 deficiency in the kidney might have promoted the blood pressure insensitivity. Uninephrectomized Id2 ϩ/Ϫ mice that received Id2 Ϫ/Ϫ kidneys were normotensive. After Ang II infusion, these mice showed a 51mm Hg increase in MAP, severe albuminuria, and renal damage. In contrast to AT1 A Ϫ/Ϫ receptor transplant experiments, kidney-transplanted mice in the present study had a high total body sodium content (Jens Titze, unpublished data, 2007). One obvious difference between the 2 studies is the AT1 receptor expression level. Although AT1 A receptor knockout mice are deficient in all kidney cell types (vessels, tubules, and glomeruli), the Id2 Ϫ/Ϫ mice in the present study had only decreased AT1 receptor expression in vessels, which was not sufficient to promote sodium excretion. These data clearly indicate that extrarenal Id2 deficiency is responsible for the phenotype.
Id2 contributes to tumorigenesis by inhibiting cell differentiation and stimulating proliferation 24 ; however, few studies have addressed the role of Id2 in cardiovascular disease. Matsumura et al 13 used a rat carotid balloon injury model and found that Id2 was expressed in a time-dependent pattern similar to the kinetics of cell proliferation. They overexpressed Id2 in smooth muscle cells in vitro and demonstrated that the Id2 protein is integrated into the cell-cycle regulatory cascade that leads to smooth muscle cell proliferation. 13 Interestingly, PPAR-␥ agonist treatment reduced expression of Id2 in smooth muscle cells. 25 PPAR-␥ agonists have been reported to inhibit neointima formation after balloon injury in association with decreased DNA synthesis. 26 PPAR-␥ might inhibit vascular injury by reducing Id2. With regard to blood pressure, several studies in animal and humans with metabolic syndrome have shown that PPAR-␥ agonists can reduce blood pressure or protect against the development of hypertension. [27] [28] [29] To our surprise, we found that VSMCs from Id2-deficent mice showed 8-fold greater PPAR-␥ and 3-fold decreased PPAR-␣ expression compared with control VSMCs. Very recently, Tordjman et al 30 demonstrated that transgenic mice with high Ang II and PPAR-␣ deficiency could not develop hypertension. Therefore, we speculate that PPAR-␣ and -␥ might have contributed to the lack of blood pressure sensitivity and vessel damage after Ang II.
The primary goal of the present study was to analyze the role of dendritic, natural killer, and memory CD8 T cells in Ang II-induced target-organ damage, because these cell types are either altered or absent in Id2 Ϫ/Ϫ mice. 14, 15, 17 There is increasing evidence that the immune system contributes actively to the pathogenesis of hypertension/Ang II-induced target-organ damage. We and others have demonstrated that immunosuppressive treatment could ameliorate target-organ damage in various nonimmune models of renal damage. 7, 31, 32 Ang II activates innate and acquired immunity via the AT1 receptor. [33] [34] [35] We have shown previously that Ang II promotes dendritic cell migration but not maturation. 7 Very recently, others reported that T cells and natural killer cells possess a functional renin-angiotensin sytem. 36 To examine the role of Langerhans dendritic, natural killer, and memory T cells, we reconstituted the lacking immune cells by bone marrow transplant. Our results in Id2 Ϫ/Ϫ mice reconstituted with wild-type bone marrow or Id2 ϩ/Ϫ mice with bone marrow from Id2 Ϫ/Ϫ mice demonstrated that none of the 3 cell types played a major role in the genesis of hypertension and target-organ damage in this model. We were surprised, because depletion of natural killer cells reduces atherosclerotic damage. 37 Despite intensive research, the relative contributions of the kidney, cardiovascular regulation, and the brain to the development of hypertension are still not fully understood. Vascular resistance is increased in hypertensive patients, and vasodilators such as calcium channel blockers and other vasodilatory drugs are generally effective in lowering blood pressure. 38, 39 Our speculation that Id2 would in particular modulate target-organ damage by influencing bone marrowderived cells was not supported by our experiments. To our surprise, Id2 by its absence precluded not only target-organ damage but also an increase in blood pressure. The bone marrow transplant experiments did not provide an explanation. The kidney transplant experiments were negative, but they were positive in the sense that after transplantation, the same phenotype persisted. Alternatively, vascular cells might play a role in the genesis of hypertension. We isolated primary VSMCs and performed Affymetrix gene expression profiling. We found a cluster of genes, which indicated that Id2 deficiency might regulate vascular senescence. Id2 ϩ/ϩ and Id2 ϩ/Ϫ VSMCs, in contrast to Id2 Ϫ/Ϫ VSMCs, showed increased SA-␤-Gal activity, typical cell morphology, reduced cell proliferation, increased expression of p16 INK4a and p21 Cip1 , and a lower level of cyclin A, all of which are features of cellular senescence. Interestingly, PPAR-␣ activation induces p16 INK4a , and PPAR-␣ gene-deleted VSMCs have decreased p16 INK4a expression. 40 Possibly, decreased PPAR-␣ expression in Id2 ϩ/Ϫ VSMCs led to decreased p16 INK4a expression and thus regulated vascular senescence. The bone morphogenetic protein-4/transforming growth factor-␤ signaling pathway is also known to be involved in the promotion of senescence. 41 We found decreased bone morphogenetic protein-4 expression in Id2-deficient VSMCs. Thus, alteration in the bone morphogenetic protein-4/transforming growth factor-␤/Id2 axis might also have contributed to the antisenescence phenotype. We are aware that the present data do not provide a causal link between vascular senescence and the genesis of hypertension. Nevertheless, there is increasing evidence that vascular senescence contributes to the pathogenesis of atherosclerosis. 42, 43 We identified a new role for the helix-loop-helix transcription factor Id2 in regulation of blood pressure and renal damage. The role of vascular senescence in the genesis of hypertension is an attractive speculation but needs to be addressed in the future. In addition, the identification of Id2 target genes might enable a better understanding of the long-term regulation of Ang II-induced vasoconstriction and target-organ damage. Finally, Id2 plays an important regulatory role in immunity, such as dendritic and T-helper cell function. Immune mechanisms are unfolding in terms of Ang II-induced hypertension and vascular dysfunction. A recent report on the role of the T cell in Ang II-mediated effects supports this view. 44 The present study points in a similar direction.
